🔎 Trials Near Me

Akèy › Limfòm selil B › Ohio › Cleveland

Etid klinik pou Limfòm selil B nan Cleveland, OH

9 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Ap rekriteFaz 1/2
  • University Hospitals Seidman Cancer Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06343311

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3
  • University Hospitals, Cleveland
  • Cleveland Clinic Foundation, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Ap rekriteFaz 1
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07225439

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Ap rekriteFaz 1
  • Clinical Trial Site, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06393738

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3
  • Cleveland Clinical Taussig Cancer Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Rainbow Babies, Cleveland
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • University Hospitals Seidman Cancer Center, Cleveland
  • Taussig Cancer Institute | Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 21, 2024 · NCT05312801

Etid Limfòm selil B nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.